课题基金 / 基金详情

Mechanisms of Bacterial Endotoxin-induced Cell Activation by a Serum-independent Pathway.

Mechanisms of Bacterial Endotoxin-induced Cell Activation by a Serum-independent Pathway.
细菌内毒素通过血清非依赖性途径诱导细胞激活的机制。
批准号:
08670315
负责人:
KIRIKAE Teruo
金额:
$1.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

KIRIKAE Teruo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The present study was done to elucidate the biological properties of LPS receptor (s) and its signal transduction system, and to identify some molecules of them. A cell line, ST2, derived from murine bone marrow stroma, was mainly used in the present study. We examined the following points ; a) responsiveness to LPS antagonists and LPS agonists, b) detection of LPS-binding proteins on the ST2 cells and production of polyclonal antisera against these proteins, c) detection of tyrosine-phosphorylated proteins on the ST2 cells. We identified some molecules which is related to LPS-induced activation of ST2 cells.1) Adaptation of CD14-negative marrow stromal ST2 cells in serum-free medium and LPS-responsiveness of ST2 cellsTo exclude completely the effects of CD14 and serum components on LPS responsiveness, we established a subclone of CD14-negative marrow stromal ST2 cells growing under serum-free conditions.2) Detection of LPS-binding proteins on ST2 sells growing under serum-free conditions.A ligand-botting method and a cross-linker method using radiolabelled LPS demonstrated a number of LPS-binding proteins on ST2 cells.3) Production of polyclonal antisera against membrane fraction containing LPS-binding proteins on ST2 cells.Rabbits were immunized with partial purified LPS-binding proteins on ST2 cells and polyclonal antisera were collected. The biological immunological properties were determined.4) Detection of tyrosine-phosphorylated proteins on ST2 sells growing under serum-free conditions.A immunoprecipitation and western blotting methods revealed tyrosine-phosphorylated proteins on ST2 sells stimulated with LPS.5) Production of monoclonal antibodies against LPS-binding proteins and their associated proteins on ST2 cells.On based our previous finding, we produced monoclonal antibodies against LPS-binding proteins and their associated proteins on ST2 cells.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
Kirikae, T., et al.: "Phodobacter sphaeroides diphosphory1 lipid A inhibits interleukin-6 production in CD14-negative murine marrow stromal ST2 cells stimulated with lipopolysaccharide or paclitaxl (taxol)." J.Endotoxin Res.4. 115-122 (1997)
Kirikae, T. 等人:“在用脂多糖或紫杉醇(紫杉醇)刺激的 CD14 阴性小鼠骨髓基质 ST2 细胞中,球形光杆菌二磷酸 1 脂质 A 抑制白细胞介素 6 的产生。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kirikae,T.,et al: "Microtubule-disrupting agents inhibitnitric oxide producation・・・・・・・・." Infection & Immunity. 64. 3379-3384 (1996)
Kirikae, T. 等人:“微管破坏剂抑制一氧化氮的产生……”感染与免疫 64. 3379-3384 (1996)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kirikae, T., et al.: "Structural significance of the benzoyl group at the C-3′-N position of paclitaxel for nitric oxide and tumor necrosis factor production by murine macrophages." Biochem.Biophys.Res.Commun.(in press).
Kirikae, T. 等人:“紫杉醇 C-3-N 位上的苯甲酰基对于小鼠巨噬细胞产生一氧化氮和肿瘤坏死因子的结构意义。”(见 Biochem.Biophys.Res.Commun。)按)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kirikae,T., et al.: "Rhodobacter Sphaeroides diphosphoryl lipid A inhibits interleukin-6 production in CD14-negative murine marrow stromal St2b cells." J.Endotoxin Res.4. 115-122 (1997)
Kirikae,T. 等人:“球形红杆菌二磷酰脂质 A 抑制 CD14 阴性小鼠骨髓基质 St2b 细胞中白细胞介素 6 的产生。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
23
    Molecular epidemiology of drug-resistant Gram-negative pathogens in Myanmar
    Mycobacterial PE_PGRS62 gene is a virulence factor during tuberculosis.
    Targeting FtsZ for antibiotics discovery
    Identification of virulent factors related to rearrangement of skeleton Proteins in mycobacterial infections.
    国内基金
    海外基金
    基于肠道菌群探讨健脾化痰方通过调节LPS/NF-κB信号通路改善多囊卵巢综合征的机制研究
    • 批准号:
      2026JJ80146
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      余曦明
    • 依托单位:
    基于肠道微生态的他莫昔芬-LPS-OTUD6A-HDAC3轴诱导乳腺癌内分泌治疗耐药的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      祝琦
    • 依托单位:
    基于肠道菌群介导的LPS/TLR4/NF-κB信号通路探讨针灸对脑缺血再灌注损伤大鼠的抑炎作用机制